![Ken Fyvie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ken Fyvie currently works at MGB Biopharma Ltd., as Chairman from 2016, Ten Bio Ltd., as Executive Chairman from 2020, and Cytomos Ltd., as Non-Executive Director.
Aktive Positionen von Ken Fyvie
| Unternehmen | Position | Beginn |
|---|---|---|
MGB Biopharma Ltd.
 MGB Biopharma Ltd. BiotechnologyHealth Technology Develops anti-infective medicines | Vorsitzender | 01.07.2016 |
Cytomos Ltd.
 Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Provides rapid label-free cell analysis for biotech research and in-vitro diagnostics using dielectric spectroscopy | Direktor/Vorstandsmitglied | - |
Ten Bio Ltd.
 Ten Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that provides ex vivo skin culture for research and lab testing | Direktor/Vorstandsmitglied | 01.09.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology Develops anti-infective medicines | Health Technology |
Cytomos Ltd.
Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Provides rapid label-free cell analysis for biotech research and in-vitro diagnostics using dielectric spectroscopy | Commercial Services |
Ten Bio Ltd.
Ten Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that provides ex vivo skin culture for research and lab testing | Commercial Services |
